Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole for prevention of stress-related mucosal damage in ICU patients
ACTRN12608000197336Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of pantoprazole in Acute Stress Gastritis (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Anti-inflammatory effects of pantoprazole in prevention of stress-related mucosal damage. Started Mar 2008; status: recruiting.
02
Drugs
pantoprazole
03
Conditions
Acute Stress Gastritis
Beyond the preview
Go deeper on ACTRN12608000197336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000197336.